Lawrence (Larry) Marnett

Forum highlights research achievements

Communication and collaboration were major themes of the inaugural Research Enterprise Forum sponsored jointly by Vanderbilt University Medical Center (VUMC) and Vanderbilt University School of Medicine (VUSM) Feb. 3 in Light Hall.

COX-2 ‘conjugate’ may slow growth of some tumors: study

More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents.

Basic Science Research Advisory Committee formed

Vanderbilt University School of Medicine (VUSM) has formed a new Basic Science Research Advisory Committee.

Cutting-edge research

Lawrence Marnett, Ph.D., second from right, talks with three Vanderbilt scientists prior to their presentations during last week’s Flexner Discovery Lecture on cutting-edge research. The speakers were, from left, Mark Wallace, Ph.D., Laura Dugan, M.D., and Sachin Patel, M.D., Ph.D.

Imaging probe for retinal disease

An imaging probe developed at Vanderbilt detects retinal inflammation early and may allow therapeutic intervention to prevent blindness.

Basic science, extraordinary impact

The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. Understanding how these cellular and molecular processes work is the focus of basic biomedical research at Vanderbilt.

1 2 3